NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
NIH funding for conferences supporting public health and scientific mission; R13 grant for high-quality events; no clinical trials allowed.
Funder: National Institutes of Health
Due Dates: April 12, 2025 (Renewal/Resubmission/Revision) | May 7, 2025 (AIDS) | August 12, 2025 (New/Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | December 12, 2025 (New/Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | April 12, 2026 (New/Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | August 12, 2026 (New/Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | December 12, 2026 (New/Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | April 12, 2027 (New/Renewal/Resubmission/Revision) | May 7, 2027 (AIDS) | August 12, 2027 (New/Renewal/Resubmission/Revision) | September 7, 2027 (AIDS)
Funding Amounts: No set budget limit; budgets must reflect actual needs. Most awards support up to 5 years for recurring conferences; single events must be applied for individually.
Summary: Supports high-quality scientific conferences and meetings relevant to public health and the NIH mission; clinical trials are not allowed.
Key Information: Advance permission to submit is required at least 6 weeks before the deadline; applications without this will not be reviewed.
Description
This opportunity provides support for high-quality scientific conferences and meetings that are relevant to public health and the mission of the National Institutes of Health (NIH) and its participating Institutes and Centers. Conferences may be in-person or virtual and can include symposia, seminars, workshops, or other organized meetings designed to exchange technical information, discuss research, or clarify a defined scientific area. The program aims to foster communication and collaboration within the research community and to advance scientific knowledge in areas of interest to NIH.
Clinical trials are not permitted under this funding opportunity.
